Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
Resource Type
Article
Authors
Aboagye, J ; Ambihapathy, W ; Baker, JF ; Beales, ER ; Boon, A ; Brampton, R ; Branch, NM ; Cooper, R ; Cornish, EL ; Cuevas-Asturias, S ; Danos, Z ; Davies, S ; de Luna George, L ; Drury, R ; Flaxman, A ; Fowler, J ; Galiza, E ; Godfrey, L ; Haskell, L ; Hillson, K ; Hultin, CL ; Koleva, S ; Lees, E ; Mabbett, R ; Muller, J ; Munro, APS ; Oliver, AL ; Owens, DR ; Pearce, JP ; Rajan, M ; Ratcliffe, H ; Rowbotham, I ; Salter, S ; Sanders, H ; Sapuan, SS ; Sharpe, H ; Sheehan, E ; Sutton, N ; Thaygaraja, G ; Thomson-Hill, S ; Ulaszewska, M ; Woods, D ; Bristol Clinical Research Nurse Team ; Li, Grace ; Cappuccini, Federica ; Marchevsky, Natalie G ; Aley, Parvinder K ; Aley, Robert ; Anslow, Rachel ; Bibi, Sagida ; Cathie, Katrina ; Clutterbuck, Elizabeth ; Faust, Saul N ; Feng, Shuo ; Heath, Paul T ; Kerridge, Simon ; Lelliott, Alice ; Mujadidi, Yama ; Ng, Khuen Foong ; Rhead, Sarah ; Roberts, Hannah ; Robinson, Hannah ; Roderick, Marion R ; Singh, Nisha ; Smith, David ; Snape, Matthew D ; Song, Rinn ; Tang, Karly ; Yao, Andy ; Liu, Xinxue ; Lambe, Teresa ; Pollard, Andrew J
Source
In The Lancet 11 June 2022 399(10342):2212-2225
Subject
Primary Research Articles
Language
ISSN
0140-6736